VALIANT LABORATORIES
|
The Current P/E Ratio of VALIANT LABORATORIES is 160.14.
Share Price | ₹142.8 | May 16,2024 |
Market Cap | ₹621.2 Cr | |
Earnings-TTM | ₹3.9 Cr | TTM-Consolidated Results |
Price/Earnings | 160.14x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VALIANT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹621.2 Cr] as on May 16,2024
(/) Earnings [ ₹3.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 160.14x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay 160.14 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VALIANT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VALIANT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VALIANT LABORATORIES
PE Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2023 averaged 0.00x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 1 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2023 at 0x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does VALIANT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VALIANT LABORATORIES | 3.88 | 160.14 | 621.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.96 | 368,598.0 |
CIPLA LTD | 4,155.31 | 27.59 | 114,654.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 17.51 | 97,429.4 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 34.36 | 101,499.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.45 | 104,348.0 |
MANKIND PHARMA LTD | 1,926.55 | 43.51 | 83,816.9 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 61.25 | 91,505.5 |
LUPIN LTD | 1,935.57 | 39.13 | 75,736.5 |
AUROBINDO PHARMA LTD | 2,777.89 | 24.47 | 67,971.8 |
ABBOTT INDIA LTD | 1,201.22 | 46.96 | 56,407.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VALIANT LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.51x |
Max industry PE | 160.14x |
Median industry PE | 40.96x |
Average industry PE | 51.94x |
You may also like the below Video Courses